REVELATION BIOSCIENCES, INC. - REVB

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$981K
QoQ value delta ($000)
+$445K (+83.02%)
Implied price effect (QoQ)
-43.49%
Shares
Total shares
1,231,042
QoQ shares delta
+850,945 (+223.88%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (REVB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 13 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
SABBY MANAGEMENT, LLC 484 605,702 0.7%
ARMISTICE CAPITAL, LLC 347 434,272 0.0%
CITADEL ADVISORS LLC 43 54,728 0.0%
VANGUARD GROUP INC 42 52,505 0.0%
GEODE CAPITAL MANAGEMENT, LLC 27 34,019 0.0%
NORTHERN TRUST CORP 17 21,907 0.0%
HRT FINANCIAL LP 12 15,320 0.0%
XTX Topco Ltd 9 11,319 0.0%
BANK OF AMERICA CORP /DE/ 0 47 0.0%
DANSKE BANK A/S 0 1 0.0%
ROYAL BANK OF CANADA 0 2 0.0%
BNP Paribas Asset Management Holding S.A. 0 38 0.0%
UBS Group AG 0 724 0.0%
SBI Securities Co., Ltd. 0 458 0.0%